News Release

European Lung Cancer Congress 2024

Prague, Czech Republic, 20-23 March

Meeting Announcement

European Society for Medical Oncology

Lugano, Switzerland, 07 March 2024 – The European Lung Cancer Congress 2024 is the annual appointment that brings together various experts in the field of thoracic oncology, including thoracic surgeons, respiratory physicians and pneumologists, medical and radiation oncologists, interventional radiologists and pathologists, to discuss the latest insights into the recent developments in the prevention, diagnosis and treatment of lung cancer. 

The event will take place in Prague, Czech Republic, and through a dedicated virtual platform between 20-23 March. 

Programme highlights 

  • Novel results in the treatment of EGFR-mutant non-small cell lung cancer 
    Related content: 3MO, 5MO, 8P, 4O 

  • Insights into the opportunities related to the use of immunotherapy, and the challenges related to IO resistance mechanisms that may occur in the treatment of patients with lung cancer 
    Related content: Sessions on 20 March, 14:30-16:00 CET and 16:30-18:00 CET, session on 21 March, 11:15-12:45 CET 

  • Prevention, screening and early diagnosis of thoracic tumours: from new technologies aimed at improving screening to prevention measures beyond smoking 
    Related content: Session on 23 March, 10:00-11:30 CET 

  • Emerging evidence on the efficacy and the management of toxicities of antibody-drug conjugates 
    Related content: 59P, 11P, Session on 23 March, 10:00-11:30 CET 

Keynote lecture 

The results of more than 240 studies from various parts of the world will be presented and published online as a supplement to ESMO Open. The abstract titles can be viewed through the online programme

Press accreditation 

ESMO welcomes press representatives working for recognised press outlets interested in obtaining information and reporting on cancer issues, upon presentation of a letter of assignment and a valid press card. Press representatives are required to observe and abide by the ESMO Policy on Press Activities. To apply for press accreditation, please fill out the form available here. Requests for press accreditation should be sent by Monday, 18 March. Please be kindly informed that onsite press accreditation will not be available.  

Further information 

ELCC Press Office  

Notes to editors  
Please make sure to use the official name of the meeting in your reports: European Lung Cancer Congress 2024 or ELCC 2024 and the official congress hashtag #ELCC24. Follow it to stay up to date and use it to take part in the conversation on X (Twitter), LinkedIn, Instagram, Facebook  

About the European Society for Medical Oncology (ESMO)   
Representing more than 35,000 oncology professionals from 172 countries worldwide, ESMO is a reference for oncology education and information. Driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to standing by those who care about cancer through addressing the diverse needs of #ONEoncologycommunity, offering #educationforLIFE, and advocating for #accessiblecancerCARE.    

About the International Association for the Study of Lung Cancer (IASLC) 
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 10,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit for more information. 

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.